Analyst rating
Based on 1 analyst giving stock ratings to GLMD in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
GLMD EPS for the last quarter is −0.62 USD despite the estimation of −0.89 USD. In the next quarter EPS is expected to reach −0.83 USD. Track more of Galmed Pharmaceuticals Ltd. financials and stay on top of what is up with the company.
In the next quarter Galmed Pharmaceuticals Ltd. revenue is expected to reach 1.45 M USD. Check out Galmed Pharmaceuticals Ltd. revenue and earnings and make informed decisions.